Lyons-Weiler: Most Recent Studies


To enable those who need these studies… last update 2/15/2021

Lyons-Weiler, 2020. Balance of Risk in COVID-19 Reveals the extreme cost of the false positives. Intern J Vacc Theor, Pract, Research 1(2):209-222. [Full Text]

https://ijvtpr.com/index.php/IJVTPR/article/view/15

Lyons-Weiler, J. 2020. Lyons-Weiler, J. 2020. Plan B public health infrastructure and operations oversight reform for America. Intl J Vacc Theor, Pract, Research 1(2):283-294. [Full Text] https://ijvtpr.com/index.php/IJVTPR/article/view/19

Lyons-Weiler J and P Thomas. 2020. Relative Incidence of Office Visits and Cumulative Rates of Billed Diagnoses Along the Axis of Vaccination. Int. J. Environ. Res. Public Health 17:8674. [Full Text] [Corrigendum] https://www.mdpi.com/1660-4601/17/22/8674

Lyons-Weiler J. 2020. Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity. J Transl Autoimmun. 2020 Apr 9:100051. doi: 10.1016/j.jtauto.2020.100051. [Full Text]

https://pubmed.ncbi.nlm.nih.gov/32292901/

Lyons-Weiler, J, G McFarland, E La Joie. 2020. Impact of catch-up vaccination on aluminum exposure due to new laws and post social distancing. J Trace Elements in Medicine and Biology 62:126649. doi: 10.1016/j.jtemb.2020.126649. [Full Text]

McFarland, G, E La Joie, P Thomas and J Lyons-Weiler. 2020. Acute Exposure and Chronic Retention of Aluminum in Three Vaccine Schedules and Effects of Genetic and Environmental Variation. J Trace Elements in Medicine and Biology 58:126444. [Full Text]

Cheikhi AM, Johnson ZI, Julian DR, Wheeler S, Feghali-Bostwick C, Conley YP, Lyons-Weiler J, Yates CC. 2020. Prediction of severity and subtype of fibrosing disease using model informed by inflammation and extracellular matrix gene index. PLoS One. 15(10):e0240986. doi: 10.1371/journal.pone.0240986. [Full Text]

Lyons-Weiler, J 2018. Autism is an Acquired Cellular Detoxification Syndrome with Genetic Heterogeneity. Autism Open Access 8(1):1-15. [Full Text]

Lyons-Weiler, J and R. Ricketson. 2018. Reconsideration of the Immunotherapeutic Pediatric Safe Dose Levels of Aluminum. Journal of Trace Elements in Medicine and Biology 48:67-73. [Full Text]

This article first appeared on jameslyonsweiler.com.

0 0 vote
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

More from James Lyons-Weiler, PhD: